SG11201804540WA - Resorbable crosslinked form stable membrane - Google Patents

Resorbable crosslinked form stable membrane

Info

Publication number
SG11201804540WA
SG11201804540WA SG11201804540WA SG11201804540WA SG11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA
Authority
SG
Singapore
Prior art keywords
collagen
international
collagen material
composite layer
inorganic ceramic
Prior art date
Application number
SG11201804540WA
Other languages
English (en)
Inventor
Niklaus Stiefel
Sergej Stenzel
Raphael Kaufmann
Original Assignee
Geistlich Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geistlich Pharma Ag filed Critical Geistlich Pharma Ag
Publication of SG11201804540WA publication Critical patent/SG11201804540WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0003—Not used, see subgroups
    • A61C8/0004—Consolidating natural teeth
    • A61C8/0006—Periodontal tissue or bone regeneration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A61F2/2846—Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Dentistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Dental Preparations (AREA)
SG11201804540WA 2015-12-04 2016-12-02 Resorbable crosslinked form stable membrane SG11201804540WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15198070.3A EP3175869A1 (fr) 2015-12-04 2015-12-04 Membrane de forme stable réticulée résorbable
PCT/EP2016/079622 WO2017093502A1 (fr) 2015-12-04 2016-12-02 Membrane stable de forme réticulée résorbable

Publications (1)

Publication Number Publication Date
SG11201804540WA true SG11201804540WA (en) 2018-06-28

Family

ID=54782622

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201804540WA SG11201804540WA (en) 2015-12-04 2016-12-02 Resorbable crosslinked form stable membrane

Country Status (20)

Country Link
US (1) US10300171B2 (fr)
EP (2) EP3175869A1 (fr)
JP (2) JP6571872B2 (fr)
KR (1) KR101918908B1 (fr)
CN (2) CN110404116A (fr)
AU (1) AU2016361929B2 (fr)
BR (1) BR112018009975B1 (fr)
CA (1) CA3006693C (fr)
DK (1) DK3233146T3 (fr)
ES (1) ES2675230T3 (fr)
HK (1) HK1245681B (fr)
HU (1) HUE037840T2 (fr)
IL (1) IL259776B (fr)
MX (1) MX2018006786A (fr)
PL (1) PL3233146T3 (fr)
PT (1) PT3233146T (fr)
RU (1) RU2733387C9 (fr)
SG (1) SG11201804540WA (fr)
TR (1) TR201809139T4 (fr)
WO (1) WO2017093502A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3175869A1 (fr) * 2015-12-04 2017-06-07 Geistlich Pharma AG Membrane de forme stable réticulée résorbable
EP3409303A1 (fr) 2017-06-02 2018-12-05 Geistlich Pharma AG Utilisation d'une composition à stabilité de forme réticulée résorbable pour préparer une membrane
WO2019115792A1 (fr) * 2017-12-14 2019-06-20 Geistlich Pharma Ag Composition d'implantation séchée et formulation d'implantation aqueuse injectable
KR101938263B1 (ko) * 2018-07-31 2019-01-14 강호창 치과용 이중구조 멤브레인의 제조방법
CA3141985C (fr) * 2019-06-14 2023-12-05 Geistlich Pharma Ag Formulation d'implant aqueuse injectable contenant de l'acide ascorbique
CN111758763B (zh) * 2020-07-07 2021-12-14 山东大树达孚特膳食品有限公司 一种肥肠去油脂设备
US12004914B2 (en) 2021-09-09 2024-06-11 Dip, Llc Customized three-dimensional scaffold for oral and maxillofacial bone grafting
CN114425104B (zh) * 2021-12-21 2023-03-03 中国人民解放军空军军医大学 一种载药骨引导/诱导复合结构及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813033D0 (en) 1988-06-02 1988-07-06 Geistlich Soehne Ag Chemical compound
JPH0788174A (ja) * 1993-09-28 1995-04-04 Yamanouchi Pharmaceut Co Ltd 骨形成用移植体
GB9400163D0 (en) 1994-01-06 1994-03-02 Geistlich Soehne Ag Membrane
JP3592920B2 (ja) * 1998-01-19 2004-11-24 独立行政法人物質・材料研究機構 有機無機配向性複合材料の製造方法
JP4790917B2 (ja) * 2001-02-23 2011-10-12 独立行政法人科学技術振興機構 人工椎体
AU784394B2 (en) * 2001-04-27 2006-03-23 Geistlich Pharma Ag Method and membrane for mucosa regeneration
GB0121985D0 (en) * 2001-09-11 2001-10-31 Isis Innovation Tissue engineering scaffolds
RU2274461C2 (ru) * 2004-02-26 2006-04-20 Сергей Дмитриевич Литвинов Материал для замещения дефектов костной ткани и способ его получения
ITMI20050343A1 (it) * 2005-03-04 2006-09-05 Fin Ceramica Faenza S R L Sostituto cartilagineo e osteocindrale comprendente una struttura multistrato e relativo impiego
JP5698680B2 (ja) * 2009-01-16 2015-04-08 ガイストリヒ・ファーマ・アクチェンゲゼルシャフトＧｅｉｓｔｌｉｃｈ Ｐｈａｒｍａ Ａｇ 皮膚再生のための方法および膜
WO2011019724A1 (fr) 2009-08-10 2011-02-17 Osseous Technologies Of America Tunnel à collagène autoporteur pour la régénération tissulaire guidée et procédé d'utilisation de celui-ci
DE102010001271B8 (de) * 2010-01-27 2012-12-06 Urotiss Gmbh Vernähbares Gewebetransplantatkonstrukt zur Rekonstruktion eines menschlichen oder tierischen Organs
GB201003656D0 (en) 2010-03-05 2010-04-21 Tigenix Ltd Fabrication process
EP2508212A1 (fr) * 2011-04-05 2012-10-10 Universitätsklinikum Freiburg Système de couche de gradient biocompatible et biodégradable pour la médecine régénérative et pour le support de tissus
RU2476236C1 (ru) * 2012-02-16 2013-02-27 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Композиционный материал для восстановления дефектов костной ткани, способ его получения и применение
TWM435257U (en) * 2012-04-27 2012-08-11 Shih-Cheng Wen Composite regeneration membrane
CN102805881B (zh) * 2012-06-18 2014-02-19 浙江星月生物科技股份有限公司 一种胶原基骨软骨三层复合物及其制备方法
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US20140193477A1 (en) 2012-10-11 2014-07-10 Emory University Collagen based materials and uses related thereto
DE102012024206A1 (de) * 2012-12-05 2014-06-18 Celgen Ag Mehrschichtige Membran für Knochendefekte
CN104922732B (zh) * 2014-03-19 2019-11-15 天新福（北京）医疗器材股份有限公司 一种口腔生物膜制备方法
EP3175869A1 (fr) 2015-12-04 2017-06-07 Geistlich Pharma AG Membrane de forme stable réticulée résorbable

Also Published As

Publication number Publication date
AU2016361929B2 (en) 2021-05-20
IL259776B (en) 2021-01-31
JP6571872B2 (ja) 2019-09-04
US20180256785A1 (en) 2018-09-13
JP2018537193A (ja) 2018-12-20
BR112018009975B1 (pt) 2020-03-10
HUE037840T2 (hu) 2018-09-28
DK3233146T3 (en) 2018-07-16
HK1245681B (zh) 2019-06-28
US10300171B2 (en) 2019-05-28
CA3006693C (fr) 2020-09-22
EP3175869A1 (fr) 2017-06-07
BR112018009975A2 (pt) 2018-11-13
RU2733387C2 (ru) 2020-10-01
ES2675230T3 (es) 2018-07-09
TR201809139T4 (tr) 2018-07-23
MX2018006786A (es) 2018-08-01
RU2733387C9 (ru) 2020-10-20
PT3233146T (pt) 2018-07-11
RU2018119921A3 (fr) 2020-01-20
CN110404116A (zh) 2019-11-05
EP3233146B1 (fr) 2018-05-09
KR20180066902A (ko) 2018-06-19
IL259776A (en) 2018-07-31
AU2016361929A1 (en) 2018-06-14
CN108289976B (zh) 2019-10-25
JP2019162503A (ja) 2019-09-26
EP3233146A1 (fr) 2017-10-25
CA3006693A1 (fr) 2017-06-08
RU2018119921A (ru) 2020-01-09
KR101918908B1 (ko) 2018-11-14
CN108289976A (zh) 2018-07-17
PL3233146T3 (pl) 2018-08-31
WO2017093502A1 (fr) 2017-06-08

Similar Documents

Publication Publication Date Title
SG11201804540WA (en) Resorbable crosslinked form stable membrane
SG11201910191RA (en) A peptide capable of forming a gel for use in tissue engineering and bioprinting
SG11201807965YA (en) Combinations of lsd1 inhibitors for use in the treatment of solid tumors
SG11201906297QA (en) Nucleic acids encoding crispr-associated proteins and uses thereof
SG11201804272RA (en) Apparatus for controlled heart valve delivery
SG11201907804QA (en) Pharmaceutical composition comprising selexipag
SG11201804152RA (en) Heterocyclic compounds as immunomodulators
SG11201901390TA (en) Tetracycline compounds and methods of treatment
SG11201810628XA (en) Nasal pharmaceutical compositions with a porous excipient
SG11201908971RA (en) Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene
SG11201907402SA (en) Population-based immunogenic peptide identification platform
SG11201807778YA (en) Bicyclic compounds for diagnosis and therapy
SG11201900618WA (en) Permanently polarized hydroxyapatite, a process for its manufacture and uses thereof
SG11201901534VA (en) Combination therapy with controlled-release cnp agonists
SG11201807972YA (en) Combinations of lsd1 inhibitors for the treatment of hematological malignancies
SG11201907604UA (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
SG11201906959RA (en) Aryl hydrocarbon receptor (ahr) modulator compounds
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201810352XA (en) New antibacterial compounds
SG11201807185UA (en) Modified hyaluronic acid, method for making same and uses thereof
SG11201807963WA (en) Compositions useful in the prevention and/or treatment of disorders of the oral cavity, upper airways and esophagus
SG11201805195YA (en) Composition comprising botulinum toxin
SG11201900471VA (en) Combination therapy for copd
SG11201901137UA (en) Silk-derived protein for treating inflammation
SG11201809882XA (en) Pharmaceutical combinations for treating cancer